Journal
IMMUNITY
Volume 54, Issue 9, Pages 1961-+Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2021.08.011
Keywords
-
Categories
Funding
- U.K. Medical Research Council (MRC)
- Wellcome Trust [100954]
- Lister Institute
- Francis Crick Institute from Cancer Research UK
- Townsend-Jeantet Charitable Trust [1011770]
- EPA Cephalosporin Early Career Researcher Fund
- MRC
Ask authors/readers for more resources
The study revealed that the adenosine deaminase ADAR1 can suppress the immunostimulatory potential of endogenous RNAs in Z-conformation, which is relevant to understanding autoinflammatory diseases in humans.
Nucleic acids are powerful triggers of innate immunity and can adopt the Z-conformation, an unusual left-handed double helix. Here, we studied the biological function(s) of Z-RNA recognition by the adenosine deaminase ADAR1, mutations in which cause Aicardi-Goutieres syndrome. Adar1(mZ alpha/mZ alpha) mice, bearing two point mutations in the Z-nucleic acid binding (Z alpha) domain that abolish Z-RNA binding, displayed spontaneous induction of type I interferons (IFNs) in multiple organs, including in the lung, where both stromal and hematopoietic cells showed IFN-stimulated gene (ISG) induction. Lung neutrophils expressed ISGs induced by the transcription factor IRF3, indicating an initiating role for neutrophils in this IFN response. The IFN response in Adar1mZ alpha/mZ alpha mice required the adaptor MAVS, implicating cytosolic RNA sensing. Adenosine-to-inosine changes were enriched in transposable elements and revealed a specific requirement of ADAR1's Z alpha domain in editing of a subset of RNAs. Thus, endogenous RNAs in Z-conformation have immunostimulatory potential curtailed by ADAR1, with relevance to autoinflammatory disease in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available